Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Gains from Investment Securities (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Gains from Investment Securities for 15 consecutive years, with $137000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 101.49% to $137000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, up 146.57% year-over-year, with the annual reading at $2.7 million for FY2025, 146.57% up from the prior year.
  • Gains from Investment Securities hit $137000.0 in Q4 2025 for Integra Lifesciences Holdings, down from $2.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $24.0 million in Q2 2022 to a low of -$9.2 million in Q4 2024.
  • Historically, Gains from Investment Securities has averaged $2.0 million across 5 years, with a median of $799000.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: surged 2598.16% in 2023 and later crashed 224.88% in 2024.
  • Year by year, Gains from Investment Securities stood at $5.3 million in 2021, then tumbled by 94.91% to $272000.0 in 2022, then soared by 2598.16% to $7.3 million in 2023, then plummeted by 224.88% to -$9.2 million in 2024, then soared by 101.49% to $137000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for IART at $137000.0 in Q4 2025, $2.8 million in Q3 2025, and -$41000.0 in Q2 2025.